Principal Financial Group Inc. Has $16.87 Million Holdings in LifeStance Health Group, Inc. $LFST

Principal Financial Group Inc. decreased its position in LifeStance Health Group, Inc. (NASDAQ:LFST) by 10.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,066,371 shares of the company’s stock after selling 349,653 shares during the quarter. Principal Financial Group Inc.’s holdings in LifeStance Health Group were worth $16,865,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Bayesian Capital Management LP bought a new position in LifeStance Health Group during the 2nd quarter worth $52,000. Blair William & Co. IL bought a new position in LifeStance Health Group during the second quarter worth about $70,000. Vanguard Personalized Indexing Management LLC bought a new position in LifeStance Health Group during the third quarter worth about $72,000. Jump Financial LLC acquired a new stake in LifeStance Health Group in the 2nd quarter worth about $79,000. Finally, Prudential Financial Inc. boosted its holdings in LifeStance Health Group by 68.6% in the 2nd quarter. Prudential Financial Inc. now owns 17,065 shares of the company’s stock valued at $88,000 after purchasing an additional 6,945 shares during the period. 85.50% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on the stock. Wall Street Zen raised shares of LifeStance Health Group from a “hold” rating to a “buy” rating in a report on Sunday. Zacks Research lowered LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of LifeStance Health Group in a research report on Monday, December 29th. Barclays assumed coverage on LifeStance Health Group in a research report on Tuesday, December 9th. They issued an “overweight” rating and a $8.00 price target on the stock. Finally, UBS Group increased their price objective on shares of LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a research note on Friday, November 7th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $9.00.

Insider Buying and Selling at LifeStance Health Group

In related news, Director Robert Bessler sold 119,942 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $7.04, for a total value of $844,391.68. Following the completion of the transaction, the director owned 1,318,983 shares in the company, valued at $9,285,640.32. This trade represents a 8.34% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Lisa K. Miller sold 57,240 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $6.43, for a total transaction of $368,053.20. Following the sale, the insider directly owned 261,292 shares in the company, valued at $1,680,107.56. The trade was a 17.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 327,326 shares of company stock worth $2,259,317. 6.60% of the stock is currently owned by insiders.

LifeStance Health Group Trading Down 0.3%

LFST opened at $6.81 on Tuesday. LifeStance Health Group, Inc. has a 1-year low of $3.74 and a 1-year high of $8.30. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 0.18. The company has a market cap of $2.65 billion, a P/E ratio of -227.00 and a beta of 1.12. The company’s 50 day moving average is $7.02 and its 200-day moving average is $5.93.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.